PMID- 37313667 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20230616 IS - 2586-6060 (Electronic) IS - 2586-6052 (Print) IS - 2586-6052 (Linking) VI - 38 IP - 2 DP - 2023 May TI - Percent fluid overload for prediction of fluid de-escalation in critically ill patients in Saudi Arabia: a prospective observational study. PG - 209-216 LID - 10.4266/acc.2022.01550 [doi] AB - BACKGROUND: Percent fluid overload greater than 5% is associated with increased mortality. The appropriate time for fluid deresuscitation depends on the patient's radiological and clinical findings. This study aimed to assess the applicability of percent fluid overload calculations for evaluating the need for fluid deresuscitation in critically ill patients. METHODS: This was a single-center, prospective, observational study of critically ill adult patients requiring intravenous fluid administration. The study's primary outcome was median percent fluid accumulation on the day of fluid deresuscitation or intensive care unit (ICU) discharge, whichever came first. RESULTS: A total of 388 patients was screened between August 1, 2021, and April 30, 2022. Of these, 100 with a mean age of 59.8+/-16.2 years were included for analysis. The mean Acute Physiology and Chronic Health Evaluation (APACHE) II score was 15.4+/-8.0. Sixty-one patients (61.0%) required fluid deresuscitation during their ICU stay, while 39 (39.0%) did not. Median percent fluid accumulation on the day of deresuscitation or ICU discharge was 4.5% (interquartile range [IQR], 1.7%-9.1%) and 5.2% (IQR, 2.9%-7.7%) in patients requiring deresuscitation and those who did not, respectively. Hospital mortality occurred in 25 (40.9%) of patients with deresuscitation and six (15.3%) patients who did not require it (P=0.007). CONCLUSIONS: The percent fluid accumulation on the day of fluid deresuscitation or ICU discharge was not statistically different between patients who required fluid deresuscitation and those who did not. A larger sample size is needed to confirm these findings. FAU - Alharbi, Reham A AU - Alharbi RA AD - Division of Pharmaceutical Care, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia. FAU - Aldardeer, Namareq F AU - Aldardeer NF AD - Division of Pharmaceutical Care, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia. FAU - Heaphy, Emily L G AU - Heaphy ELG AD - Department of Research, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia. FAU - Alabbasi, Ahmad H AU - Alabbasi AH AD - Nahdi Medical Company, Medina, Saudi Arabia. FAU - Albuqami, Amjad M AU - Albuqami AM AD - United Pharmacy, Jeddah, Saudi Arabia. FAU - Hawa, Hassan AU - Hawa H AD - Joint CCT in Acute and Intensive Care Medicine (UK), Department of Critical Care Medicine, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia. LA - eng PT - Journal Article DEP - 20230516 PL - Korea (South) TA - Acute Crit Care JT - Acute and critical care JID - 101726905 PMC - PMC10265412 OTO - NOTNLM OT - critical care OT - de-escalation OT - fluid overload OT - prospective COIS- CONFLICT OF INTEREST No potential conflict of interest relevant to this article was reported. EDAT- 2023/06/14 06:42 MHDA- 2023/06/14 06:43 PMCR- 2023/05/01 CRDT- 2023/06/14 04:35 PHST- 2022/12/16 00:00 [received] PHST- 2023/02/28 00:00 [accepted] PHST- 2023/06/14 06:43 [medline] PHST- 2023/06/14 06:42 [pubmed] PHST- 2023/06/14 04:35 [entrez] PHST- 2023/05/01 00:00 [pmc-release] AID - acc.2022.01550 [pii] AID - acc-2022-01550 [pii] AID - 10.4266/acc.2022.01550 [doi] PST - ppublish SO - Acute Crit Care. 2023 May;38(2):209-216. doi: 10.4266/acc.2022.01550. Epub 2023 May 16.